These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 25922939

  • 1. Atypical antipsychotics as augmentation therapy in anorexia nervosa.
    Marzola E, Desedime N, Giovannone C, Amianto F, Fassino S, Abbate-Daga G.
    PLoS One; 2015; 10(4):e0125569. PubMed ID: 25922939
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
    Cheon EJ, Lee KH, Park YW, Lee JH, Koo BH, Lee SJ, Sung HM.
    J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine therapy in anorexia nervosa: psychobiological effects.
    Brambilla F, Garcia CS, Fassino S, Daga GA, Favaro A, Santonastaso P, Ramaciotti C, Bondi E, Mellado C, Borriello R, Monteleone P.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642
    [Abstract] [Full Text] [Related]

  • 4. [Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].
    Weimer E, Braus DF, Cavus I, Thome J.
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):210-7. PubMed ID: 11948436
    [Abstract] [Full Text] [Related]

  • 5. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
    Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ.
    J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
    [Abstract] [Full Text] [Related]

  • 6. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
    Dold M, Aigner M, Lanzenberger R, Kasper S.
    Int J Neuropsychopharmacol; 2015 May 04; 18(9):. PubMed ID: 25939614
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study.
    Ozaki N, Otsubo T, Kato M, Higuchi T, Ono H, Kamijima K, ADMIRE Study Group.
    Psychiatry Clin Neurosci; 2015 Jan 04; 69(1):34-42. PubMed ID: 24965202
    [Abstract] [Full Text] [Related]

  • 8. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.
    Dold M, Aigner M, Lanzenberger R, Kasper S.
    Int J Neuropsychopharmacol; 2013 Apr 04; 16(3):557-74. PubMed ID: 22932229
    [Abstract] [Full Text] [Related]

  • 9. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.
    Stewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, Jenike MA.
    J Clin Psychopharmacol; 2010 Feb 04; 30(1):34-9. PubMed ID: 20075645
    [Abstract] [Full Text] [Related]

  • 10. A case series of aripiprazole augmentation of selective serotonin reuptake inhibitors in treatment-refractory obsessive compulsive disorder.
    Matsunaga H, Hayashida K, Maebayashi K, Mito H, Kiriike N.
    Int J Psychiatry Clin Pract; 2011 Nov 04; 15(4):263-9. PubMed ID: 22121999
    [Abstract] [Full Text] [Related]

  • 11. Olanzapine use in adolescent anorexia nervosa.
    Dennis K, Le Grange D, Bremer J.
    Eat Weight Disord; 2006 Jun 04; 11(2):e53-6. PubMed ID: 16809970
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
    Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD.
    Am J Psychiatry; 2019 Jun 01; 176(6):449-456. PubMed ID: 30654643
    [Abstract] [Full Text] [Related]

  • 13. Olanzapine augmentation of serotonin uptake inhibitors in obsessive-compulsive disorder: an open study.
    Francobandiera G.
    Can J Psychiatry; 2001 May 01; 46(4):356-8. PubMed ID: 11387793
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.
    Ak M, Bulut SD, Bozkurt A, Ozsahin A.
    Adv Ther; 2011 Apr 01; 28(4):341-8. PubMed ID: 21437763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.
    Mondraty N, Birmingham CL, Touyz S, Sundakov V, Chapman L, Beumont P.
    Australas Psychiatry; 2005 Mar 01; 13(1):72-5. PubMed ID: 15777417
    [Abstract] [Full Text] [Related]

  • 18. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
    Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J.
    BMC Psychiatry; 2014 Nov 29; 14():317. PubMed ID: 25432131
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.